The Pitt’s commanding 96% market-implied odds reflect its status as the clear frontrunner for Outstanding Drama Series at the 2026 Emmys. As the reigning champion from its acclaimed first season, the HBO Max medical drama earned a leading 25 nominations for Season 2, building on strong critical reception, Golden Globe success, and early Creative Arts momentum including guest acting wins. Industry consensus highlights its consistent ensemble strength and voter familiarity, outpacing competitors like Pluribus despite that newcomer’s solid nomination haul. Realistic upset paths remain narrow and would likely require a late surge in guild or precursor support for an alternative such as Pluribus or Slow Horses, though historical patterns favor the established frontrunner heading into final voting.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedEmmys 2026: Outstanding drama series
“The Pitt” 95.9%
“A Knight of the Seven Kingdoms” 1.6%
"The Diplomat" 1.3%
“Paradise” 1.1%
$36,318 Vol.
$36,318 Vol.
“The Pitt”
96%
“A Knight of the Seven Kingdoms”
2%
"The Diplomat"
1%
“Paradise”
1%
“The Gilded Age”
1%
“Your Friends & Neighbors”
1%
“Slow Horses”
<1%
“The Pitt” 95.9%
“A Knight of the Seven Kingdoms” 1.6%
"The Diplomat" 1.3%
“Paradise” 1.1%
$36,318 Vol.
$36,318 Vol.
“The Pitt”
96%
“A Knight of the Seven Kingdoms”
2%
"The Diplomat"
1%
“Paradise”
1%
“The Gilded Age”
1%
“Your Friends & Neighbors”
1%
“Slow Horses”
<1%
This market will resolve according to the nominee who wins the 2026 Emmy award for “Outstanding drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Market Opened: Jul 10, 2026, 10:18 AM ET
Resolver
0x69c47De9D...This market will resolve according to the nominee who wins the 2026 Emmy award for “Outstanding drama series”.
If for any reason no winner is declared by October 31, 2026, 11:59 PM ET, or in case of overall cancellation or a tie for winner, this market will resolve in favor of the nominee which comes first in alphabetical order.
The primary resolution source for this market will be official information from the Academy of Television Arts & Sciences and the Emmys, including data from their websites (e.g. https://theemmys.tv/, https://www.televisionacademy.com/) and the live broadcast of the award ceremony, however a consensus of credible reporting may also be used.
Resolver
0x69c47De9D...The Pitt’s commanding 96% market-implied odds reflect its status as the clear frontrunner for Outstanding Drama Series at the 2026 Emmys. As the reigning champion from its acclaimed first season, the HBO Max medical drama earned a leading 25 nominations for Season 2, building on strong critical reception, Golden Globe success, and early Creative Arts momentum including guest acting wins. Industry consensus highlights its consistent ensemble strength and voter familiarity, outpacing competitors like Pluribus despite that newcomer’s solid nomination haul. Realistic upset paths remain narrow and would likely require a late surge in guild or precursor support for an alternative such as Pluribus or Slow Horses, though historical patterns favor the established frontrunner heading into final voting.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions